Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2016 046 230.3 |
96 | EP file number | EAKZ | 16 73 8288.6 |
86 | WO file number | WAKZ | PCT/US2016/039198 |
97 | EP publication number | EPN | 3313444 |
87 | WO publication number | WPN | 2016210240 |
54 | Designation/title | TI | KOMBINATIONSTHERAPIE AUS HERZMYOSINAKTIVATOR UND SINUSKNOTEN-IF-STROMINHIBITOR |
51 | IPC main class | ICM (ICMV) | A61K 45/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/496 (2006.01), A61K 31/55 (2006.01), A61P 9/04 (2006.01), A61K 45/06 (2006.01) |
22 | DE application date | DAT | Jun 24, 2016 |
96 | EP application date | EAT | Jun 24, 2016 |
86 | WO application date | WAT | Jun 24, 2016 |
43 | Date of first publication | OT | Dec 29, 2016 |
| Date of publication of grant | PET | Oct 21, 2020 |
71/73 | Applicant/owner | INH | Amgen, Inc, Thousand Oaks, CA, US; Cytokinetics, Inc., South San Francisco, CA, US |
72 | Inventor | IN | SCOTT, Robert, Andrew Donald, Thousand Oaks, CA 91362, US; WASSERMAN, Scott, Newbury Park, CA 91320, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562185306 P Jun 26, 2015
|
| Due date | FT FG | Jun 30, 2026 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003313444A1 Searchable text:
EP000003313444A1 Original document:
EP000003313444B1 Searchable text:
EP000003313444B1 Original document:
WO002016210240 Searchable text:
WO002016210240 |
43 | Date of first publication | EVT | Dec 29, 2016 |
| Date of the first transfer into DPMAregister | EREGT | May 2, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 10, 2025 (Show all update days)(Hide all update days)- Apr 10, 2025
- Sep 26, 2024
- St.36: changed (technical change)
- Jun 27, 2024; May 9, 2024; Apr 11, 2024; May 10, 2023; May 14, 2022; Apr 28, 2022; Apr 13, 2022; Oct 14, 2021; Sep 9, 2021; Jun 3, 2021; Dec 29, 2020; Nov 12, 2020; Oct 2, 2020; Oct 1, 2020; Aug 22, 2019; May 30, 2019
- Historical data not available for this/these date(s)
- May 2, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 12, 2022 |
| Issue number | HN | 20 |
| Year | PJ | 2022 |
| Publication date | VT | May 19, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Amgen, Inc, Thousand Oaks, CA, US; Cytokinetics, Inc., South San Francisco, CA, US |
71/73 | Previous applicant/owner | INHF | Amgen, Inc., Thousand Oaks, Calif., US |
| Date of update of the procedure | REGT | Apr 28, 2022 |